The Italian study was performed to assess the safety and efficacy of expanded CD4+CD25+ human nTreg in prevention of GvHD in 28 patients with high-risk acute leukaemias undergoing HLA-haploidentical HSC transplants. This evidence concerns the gene CD4 and graft versus host disease.